Your browser doesn't support javascript.
loading
Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics.
Li, Qingke; Chen, Qu; Klauser, Paul C; Li, Mengyuan; Zheng, Feng; Wang, Nanxi; Li, Xiaoying; Zhang, Qianbing; Fu, Xuemei; Wang, Qian; Xu, Yang; Wang, Lei.
  • Li Q; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, China; Hangzhou Research Institute of Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Hangzho
  • Chen Q; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, China; The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong 518033, China.
  • Klauser PC; Department of Pharmaceutical Chemistry and the Cardiovascular Research Institute, University of California-San Francisco, San Francisco, CA 94158, USA.
  • Li M; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, China; Hangzhou Research Institute of Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Hangzho
  • Zheng F; Hangzhou Research Institute of Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Hangzhou 310018, China.
  • Wang N; Department of Pharmaceutical Chemistry and the Cardiovascular Research Institute, University of California-San Francisco, San Francisco, CA 94158, USA.
  • Li X; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, China.
  • Zhang Q; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, China.
  • Fu X; The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong 518033, China.
  • Wang Q; Hangzhou Research Institute of Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Hangzhou 310018, China. Electronic address: qianwang@mail.ipc.ac.cn.
  • Xu Y; Cancer Research Institute, Guangdong Provincial Key Laboratory of Cancer Immunotherapy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, China; The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong 518033, China. Electronic address: xu
  • Wang L; Department of Pharmaceutical Chemistry and the Cardiovascular Research Institute, University of California-San Francisco, San Francisco, CA 94158, USA. Electronic address: lei.wang2@ucsf.edu.
Cell ; 182(1): 85-97.e16, 2020 07 09.
Article en En | MEDLINE | ID: mdl-32579975
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Proteínas Límite: Animals / Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Proteínas Límite: Animals / Humans Idioma: En Año: 2020 Tipo del documento: Article